参考文献/References:
[1] 钟 亮,刘清壮,蔡茂德.Ⅲ、Ⅳ期上皮性卵巢癌术后腹腔辅助化疗临床观察[J].陕西医学杂志,2020,49(2):193-196.
[2] 李钰捷,高 嵩.线粒体外膜融合机制的研究进展[J].中国基础科学,2020,22(3):5-9,52.
[3] 贾建博,辛少伟,王 涛,等.线粒体动态蛋白MiD51在肺癌细胞增殖与凋亡中的调控作用探讨[J].现代肿瘤医学,2019,15(8):102-110.
[4] 牛菲菲,徐 红,王飞艳.子宫内膜癌组织中促凋亡线粒体蛋白BNIP3的表达及意义[J].山东医药,2013,53(26):12-14.
[5] 李成斐,朱 萍,于 佳,等.益气活血解毒方联合化疗治疗晚期卵巢癌疗效及对患者免疫通路相关靶基因的影响[J].陕西中医,2021,42(8):1072-1075,1079.
[6] 杨 勇,王 冰.人绒毛膜促性腺激素、人附睾蛋白4、糖类抗原199联合检测对卵巢肿瘤的诊断价值[J].陕西医学杂志,2019,48(8):1091-1093.
[7] Dai W,Wang G,Chwa J,et al.Mitochondrial division inhibitor(mdivi-1)decreases oxidative metabolism in cancer[J].Br J Cancer,2020,122(9):1288-1297.
[8] 刘彦斌,聂 娜,李 娟,等.线粒体分裂蛋白MiD51在HBV相关肝癌转移中的调控作用[J].海南医学,2019,22(13):1029-1034.
[9] 周晓丰,张百红.肿瘤发生的理论模式[J].现代肿瘤医学,2018,26(4):627-630.
[10] Atkins K,Dasguota A,Chen KH,et al.The role of DRP1 adaptor proteins MiD49 and MiD51 in mitochondrial fission:Implications for human disease[J].Clin Sci(Lond),2016,130(21):1861-1874.
[11] 徐颖琼,周科成,赵亚铮,等.线粒体融合与分裂在中枢神经系统疾病中的研究进展[J].现代生物医学进展,2018,18(7):202-206.
[12] Liang X,Dang S.Mitochondrial dynamics related genes-MFN1,MFN2 and DRP1 polymorphisms are associated with risk of lung cancer[J].Pharmgenomics Pers Med,2021,14(9):695-703.
[13] 申菲菲,郭 睿,赵树鹏,等.线粒体分裂在甲状腺鳞癌SW579细胞增殖、凋亡以及侵袭中的作用[J].天津医药,2015,20(2):129-133.
[14] Woo SM,Min KJ,Kwon TK.Inhibition of DRP1 sensitizes cancer cells to cisplatin-induced apoptosis through transcriptional inhibition of c-FLIP expression[J].Molecules,2020,25(24):120-129.
[15] Padder RA,Bhat ZI,Ahmad Z,et al.DRP1 promotes BRAF(V600E)-driven tumor progression and metabolic reprogramming in colorectal cancer[J].Front Oncol,2020,10(8):592-601.
[16] Dasgupta A,Chen KH,Wu D,et al.An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer:Diagnostic and therapeutic implications[J].FASEB J,2020,34(4):5106-5117.
[17] Zhang L,Cao H,Tao H,et al.Effect of the interference with DRP1 expression on the biological characteristics of glioma stem cells[J].Exp Ther Med,2021,22(1):696-705.
[18] 樊伟平,杜欣娜,陈文艳,等.基于TCGA泛癌症分析线粒体裂变调节因子1的表达和预后意义[J].现代肿瘤医学,2020,28(4):648-651.
[19] Zhao L,Liu Z,Deng X,et al.Polyphyllin Ⅶ induces mitochondrial apoptosis by regulating the PP2A/AKT/DRP1 signaling axis in human ovarian cancer[J].Oncol Rep,2021,45(2):513-522.
[20] Schultz J,Warkus J,Wolke C,et al.MiD51 is important for maintaining mitochondrial health in pancreatic islet and MIN6 cells[J].Front Endocrinol(Lausanne),2020,11(8):232-240.
[21] Qian W,Salamoun J,Wang J,et al.The combination of thioxodihydroquinazolinones and platinum drugs reverses platinum resistance in tumor cells by inducing mitochondrial apoptosis independent of Bax and Bak[J].Bioorg Med Chem Lett,2015,25(4):856-863.
[22] Liu B,Fan Y,Song Z,et al.Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer[J].Int Immunopharmacol,2020,89(10):1070-1078.
相似文献/References:
[1]刘瑞丽,刘小红,李会荣,等.主动循环腹腔热灌注化疗治疗卵巢癌伴腹腔积液效果观察*[J].陕西医学杂志,2019,(12):1630.
LIU Ruili,LIU Xiaohong,LI Huirong,et al.Curative effect of active circulation intraperitoneal hyperthermic perfusion chemotherapy on ovarian cancer combined with seroperitoneum and its influences on prognosis[J].,2019,(12):1630.
[2]段小霞,郭 华,付 婷,等.震颤同系物-5过表达对卵巢癌细胞A2780增殖和凋亡的影响[J].陕西医学杂志,2022,51(5):529.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.004]
DUAN Xiaoxia,GUO Hua,FU Ting,et al.Effect of quaking homolog-5 overexpression on proliferation and apoptosis of ovarian cancer cell line A2780[J].,2022,51(12):529.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.004]
[3]耿海慧,曹爱华.卵巢癌患者多种血清肿瘤标志物表达水平及其对疾病的诊断价值研究[J].陕西医学杂志,2022,51(7):886.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.029]
GENG Haihui,CAO Aihua.Expression levels of various serum tumor markers in ovarian cancer patients and their diagnostic value for the disease[J].,2022,51(12):886.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.029]
[4]王 静,张虹宇,张 磊,等.动脉灌注分数联合转化生长因子-β及上皮细胞钙黏蛋白检测对原发性卵巢癌的诊断价值研究[J].陕西医学杂志,2023,52(7):858.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.019]
[5]王 静,张虹宇,张 磊,等.动脉灌注化疗联合细胞因子诱导杀伤细胞治疗晚期卵巢癌疗效及对患者血清癌胚抗原、糖类抗原125、可溶性B7-H4蛋白水平的影响[J].陕西医学杂志,2024,(2):199.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.011]
WANG Jing,ZHANG Hongyu,ZHANG Lei,et al.Efficacy of arterial infusion chemotherapy combined with CIK in the treatment of advanced ovarian cancer and its effect on serum levels of carcinoembryonic antigen,carbohydrate antigen 125 and soluble B7-H4 protein[J].,2024,(12):199.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.011]
[6]刘玉锋,薛芳芳.卵巢癌患者造血前B细胞白血病转录因子相互作用蛋白表达和术前中性粒细胞与淋巴细胞比值水平及其临床检测价值[J].陕西医学杂志,2024,(5):662.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.019]
[7]冷小飞,张逸群,魏 峰,等.长链非编码RNA RP11-572P18.1对卵巢癌细胞增殖和侵袭的影响及作用机制实验研究[J].陕西医学杂志,2024,(8):1011.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.001]
LENG Xiaofei,ZHANG Yiqun,WEI Feng,et al.Effect of long non-coding RNA RP11-572P18.1 on the proliferation and invasion of ovarian cancer cells and its mechanism[J].,2024,(12):1011.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.001]
[8]司 晗,李洁妹,宗佳琪,等.高糖环境对卵巢癌细胞侵袭和迁移的影响及其机制实验研究[J].陕西医学杂志,2024,(8):1016.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.002]
SI Han,LI Jiemei,ZONG Jiaqi,et al.Effect of high glucose environment on the invasion and migration of ovarian cancer cells and its mechanism[J].,2024,(12):1016.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.002]
[9]王 静,张虹宇,张 磊,等.长链非编码RNA PVT1调控表皮生长因子受体/有丝分裂原活性蛋白激酶通路对卵巢癌细胞的影响实验研究[J].陕西医学杂志,2024,(11):1454.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.003]
WANG Jing,ZHANG Hongyu,ZHANG Lei,et al.Effect of long non-coding RNA PVT1 on ovarian cancer cells by regulating epidermal growth factor receptor/mitogen-activated protein kinase pathway[J].,2024,(12):1454.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.003]
[10]周佳敏,赵诗杰,朱小兰,等.RNA甲基化修饰在卵巢癌中的作用研究进展[J].陕西医学杂志,2024,(11):1571.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.029]
ZHOU Jiamin,ZHAO Shijie,ZHU Xiaolan,et al.Research progress on the role of RNA methylation modifications in ovarian cancer[J].,2024,(12):1571.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.029]